O

Omnicure Clinical Research | Doral, FL

Research site

(Unclaimed)

Location

8880 NW 20 St Suite M, Doral, Florida, United States of America

Site insights

Top conditions

Top treatments

Alectinib

Dupilumab

Remibrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines (RECLAIM)

This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\]...

Enrolling

Chronic Spontaneous Urticaria (CSU)

Drug: Placebo solution for injection

Drug: Dupilumab

Pharmacogenomics IND EXEMPT SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms (Drugs-SNPs)

Explore the relationship between drug target ALK gene single nucleotide polymorphisms and ALECENSA - Alectinib therapeutic-effects in patients with n...

Active, not recruiting

Non-small Cell Lung Cancer

Drug: Alectinib - Study

Drug: Alectinib - Usual

Trial sponsors

H

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms